Owens & MinorOMI
OMI
0
Funds holding %
of 7,390 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
1,134% more call options, than puts
Call options by funds: $1.89M | Put options by funds: $153K
0% more funds holding in top 10
Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]
1.02% less ownership
Funds ownership: 99.54% [Q3] → 98.52% (-1.02%) [Q4]
8% less funds holding
Funds holding: 212 [Q3] → 196 (-16) [Q4]
14% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 73
17% less capital invested
Capital invested by funds: $1.2B [Q3] → $993M (-$207M) [Q4]
35% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 40
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$10
17%
upside
Avg. target
$11.33
32%
upside
High target
$13
52%
upside
3 analyst ratings
1 positive
33%
1 neutral
33%
1 negative
33%
JP Morgan Michael Minchak 100% 1-year accuracy 1 / 1 met price target | 17%upside $10 | Underweight Maintained | 10 Mar 2025 |
Baird Eric Coldwell 42% 1-year accuracy 14 / 33 met price target | 28%upside $11 | Neutral Maintained | 3 Mar 2025 |
UBS Kevin Caliendo 50% 1-year accuracy 7 / 14 met price target | 52%upside $13 | Buy Maintained | 13 Feb 2025 |
Financial journalist opinion
Based on 3 articles about OMI published over the past 30 days
Neutral
Business Wire
4 days ago
Owens & Minor Announces Launch of Senior Secured Notes Offering
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE:OMI) (the “Company”) announced today that it has launched a private offering (the “Offering”) of $600 million aggregate principal amount of senior secured notes due 2030 (the “Notes”), subject to customary and market conditions. Unless the previously announced acquisition (the “Acquisition”) of Rotech Healthcare Holdings Inc. (“Rotech”) is consummated concurrently with or promptly following the closing of the Offering, the Company wi.

Positive
Zacks Investment Research
3 weeks ago
Owens & Minor Shares Surge 39% on Earnings Beat and Growth Plans
OMI's shares witnessed a massive uptick after the company posted stronger-than-expected Q4 earnings. Its strategic focus on Patient Direct and the Rotech acquisition indicates long-term shareholder value.

Neutral
Accesswire
4 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Owens & Minor, Inc. - OMI
NEW YORK, NY / ACCESS Newswire / March 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc ("Owens & Minor" or the "Company") (NYSE:OMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

Neutral
Seeking Alpha
1 month ago
Owens & Minor, Inc. (OMI) Q4 2024 Earnings Call Transcript
Owens & Minor, Inc. (NYSE:OMI ) Q4 2024 - Earnings Conference Call February 28, 2025 8:30 AM ET Company Participants Jackie Marcus – IR Edward Pesicka - President and CEO Jonathan Leon - CFO Conference Call Participants Kevin Caliendo - UBS Michael Cherny - Leerink Partners John Stansel - JP Morgan Daniel Grosslight - Citigroup Eric Coldwell - Baird Allen Lutz - Bank of America Operator Good day and thank you for standing by. Welcome to the Owens & Minor Fourth Quarter and Full Year 2024 Earnings Conference Call.

Positive
Benzinga
1 month ago
Healthcare Logistics Firm Owens & Minor Reports Better-Than-Expected Q4 Earnings, Plans To Repurchase $100 Million In Shares
On Monday, Owens & Minor Inc. OMI reported adjusted EPS of $0.45 for the fourth quarter of 2024, down from $0.69 a year ago but beating the consensus of $0.52.

Positive
Zacks Investment Research
1 month ago
Owens & Minor (OMI) Tops Q4 Earnings and Revenue Estimates
Owens & Minor (OMI) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.69 per share a year ago.

Neutral
Business Wire
1 month ago
Owens & Minor Reports Fourth Quarter & Full Year Financial Results and Announces Sale Process Underway for Products & Healthcare Services Segment
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the fourth quarter and year ended December 31, 2024. “We are pleased with the progress that we have made against the strategy as outlined at our Investor Day in December 2023. As a reminder, we committed to optimizing our Products & Healthcare Services business, leveraging our leading Patient Direct platform, and building balance sheet flexibility through deleveraging. Within P&HS we.

Neutral
Accesswire
1 month ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Owens & Minor, Inc. - OMI
NEW YORK, NY / ACCESS Newswire / February 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc ("Owens & Minor" or the "Company") (NYSE:OMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

Neutral
PRNewsWire
1 month ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Owens & Minor, Inc. - OMI
NEW YORK , Feb. 25, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc ("Owens & Minor" or the "Company") (NYSE:OMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

Neutral
Accesswire
1 month ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Owens & Minor, Inc. - OMI
NEW YORK CITY, NY / ACCESS Newswire / February 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc ("Owens & Minor" or the "Company") (NYSE:OMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

Charts implemented using Lightweight Charts™